Heart drug trial halted before it began: no patients enrolled
Symptom relief
Terminated
This study was designed to test a new drug, IMB-1018972, in people with refractory angina—chest pain that doesn't improve with standard treatments. The goal was to see if the drug could safely help patients exercise longer and have fewer angina episodes. However, the trial was wi…
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 28, 2026 13:02 UTC